Trillium Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11M | Sell |
91,372
-4,821
| -5% | -$557K | 0.37% | 76 |
|
|
2025
Q4 | $10.2M | Sell |
96,193
-9,034
| -9% | -$848K | 0.31% | 79 |
|
|
2025
Q3 | $8.83M | Sell |
105,227
-8,354
| -7% | -$688K | 0.23% | 96 |
|
|
2025
Q2 | $8.99M | Sell |
113,581
-14,902
| -12% | -$1.18M | 0.24% | 93 |
|
|
2025
Q1 | $11.5M | Sell |
128,483
-250,422
| -66% | -$23.4M | 0.33% | 87 |
|
|
2024
Q4 | $37.7M | Sell |
378,905
-13,416
| -3% | -$1.38M | 0.98% | 25 |
|
|
2024
Q3 | $44.6M | Sell |
392,321
-5,773
| -1% | -$686K | 1.09% | 23 |
|
|
2024
Q2 | $49.3M | Sell |
398,094
-64,382
| -14% | -$8.29M | 1.24% | 17 |
|
|
2024
Q1 | $61M | Sell |
462,476
-3,075
| -0.7% | -$379K | 1.55% | 10 |
|
|
2023
Q4 | $50.8M | Sell |
465,551
-12,346
| -3% | -$1.28M | 1.38% | 13 |
|
|
2023
Q3 | $49.2M | Sell |
477,897
-31,696
| -6% | -$3.42M | 1.48% | 11 |
|
|
2023
Q2 | $58.8M | Sell |
509,593
-405
| -0.1% | -$46K | 1.65% | 6 |
|
|
2023
Q1 | $58.4M | Buy |
509,998
+42,602
| +9% | +$4.6M | 1.71% | 7 |
|
|
2022
Q4 | $51.9M | Sell |
467,396
-10,419
| -2% | -$1.06M | 1.6% | 10 |
|
|
2022
Q3 | $41.1M | Sell |
477,815
-4,334
| -0.9% | -$387K | 1.35% | 15 |
|
|
2022
Q2 | $43.9M | Buy |
482,149
+50,456
| +12% | +$4.47M | 1.35% | 14 |
|
|
2022
Q1 | $35.4M | Sell |
431,693
-30,427
| -7% | -$2.4M | 0.94% | 35 |
|
|
2021
Q4 | $35.4M | Buy |
462,120
+7,383
| +2% | +$588K | 0.83% | 40 |
|
|
2021
Q3 | $34.2M | Buy |
454,737
+15,425
| +4% | +$1.17M | 0.9% | 35 |
|
|
2021
Q2 | $34.1M | Sell |
439,312
-13,571
| -3% | -$1.01M | 0.94% | 31 |
|
|
2021
Q1 | $33.3M | Sell |
452,883
-72,136
| -14% | -$5.32M | 1.05% | 27 |
|
|
2020
Q4 | $41M | Buy |
525,019
+1,785
| +0.3% | +$137K | 1.47% | 14 |
|
|
2020
Q3 | $41.4M | Sell |
523,234
-36,173
| -6% | -$2.83M | 1.74% | 9 |
|
|
2020
Q2 | $41.3M | Buy |
559,407
+4,775
| +0.9% | +$359K | 1.76% | 7 |
|
|
2020
Q1 | $40.7M | Buy |
554,632
+50,440
| +10% | +$3.96M | 2.14% | 5 |
|
|
2019
Q4 | $43.8M | Buy |
504,192
+10,238
| +2% | +$841K | 1.95% | 5 |
|
|
2019
Q3 | $39.7M | Buy |
493,954
+6,353
| +1% | +$509K | 1.85% | 7 |
|
|
2019
Q2 | $39M | Sell |
487,601
-2,404
| -0.5% | -$184K | 1.88% | 6 |
|
|
2019
Q1 | $38.9M | Sell |
490,005
-734
| -0.1% | -$54.9K | 1.97% | 5 |
|
|
2018
Q4 | $35.8M | Sell |
490,739
-2,550
| -0.5% | -$180K | 2.07% | 3 |
|
|
2018
Q3 | $33.4M | Buy |
493,289
+1,925
| +0.4% | +$123K | 1.67% | 7 |
|
|
2018
Q2 | $28.5M | Buy |
491,364
+21,964
| +5% | +$1.24M | 1.52% | 10 |
|
|
2018
Q1 | $24.4M | Buy |
469,400
+16,800
| +4% | +$907K | 1.35% | 14 |
|
|
2017
Q4 | $24.3M | Sell |
452,600
-16,958
| -4% | -$940K | 1.34% | 12 |
|
|
2017
Q3 | $28.7M | Buy |
469,558
+14,305
| +3% | +$867K | 1.64% | 7 |
|
|
2017
Q2 | $27.8M | Buy |
455,253
+6,682
| +1% | +$407K | 1.66% | 5 |
|
|
2017
Q1 | $27.2M | Buy |
448,571
+2,793
| +0.6% | +$169K | 1.74% | 2 |
|
|
2016
Q4 | $25M | Buy |
445,778
+2,147
| +0.5% | +$126K | 1.65% | 4 |
|
|
2016
Q3 | $26.4M | Buy |
443,631
+112,295
| +34% | +$6.57M | 1.7% | 4 |
|
|
2016
Q2 | $18.2M | Buy |
331,336
+6,543
| +2% | +$348K | 1.2% | 19 |
|
|
2016
Q1 | $16.4M | Buy |
324,793
+132,755
| +69% | +$6.5M | 1.09% | 28 |
|
|
2015
Q4 | $9.68M | Buy |
192,038
+68,869
| +56% | +$3.47M | 0.65% | 66 |
|
|
2015
Q3 | $5.8M | Buy |
123,169
+16,558
| +16% | +$880K | 0.41% | 89 |
|
|
2015
Q2 | $5.79M | Buy |
106,611
+352
| +0.3% | +$19.7K | 0.37% | 101 |
|
|
2015
Q1 | $5.83M | Buy |
106,259
+6,886
| +7% | +$390K | 0.38% | 100 |
|
|
2014
Q4 | $5.38M | Buy |
+99,373
| New | +$5.54M | 0.37% | 108 |
|
|
2014
Q1 | – | Sell |
-4,288
| Closed | -$205K | – | 182 |
|
|
2013
Q4 | $205K | Sell |
4,288
-7,872
| -65% | -$360K | 0.02% | 177 |
|
|
2013
Q3 | $552K | Buy |
+12,160
| New | +$555K | 0.06% | 151 |
|
Other funds holding MRK
VCM
VPM
Trillium Asset Management's MRK Position: Q1 2026 in Review
Trillium Asset Management reduced its Merck (MRK) stake by 5% in Q1 2026, selling an estimated $557K and leaving 91,372 shares worth $11M. The position accounts for 0.37% of the portfolio, ranked #76.
Trillium Asset Management first reported a position in MRK in Q3 2013 and has held it in 48 quarters since. The position peaked at $61M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Trillium Asset Management held 91,372 shares of Merck worth $11M as of Q1 2026.
- Trillium Asset Management sold 4,821 Merck shares in Q1 2026, an estimated $557K.
- Merck made up 0.37% of Trillium Asset Management's portfolio in Q1 2026, its #76 holding.
- Trillium Asset Management first reported a position in Merck in Q3 2013 and has held it in 48 quarters since.
- Trillium Asset Management's Merck position peaked at $61M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Trillium Asset Management's 13F filing for Q1 2026, filed 11 May 2026.